倾向得分匹配
医学
腺癌
阶段(地层学)
混淆
肺癌
病态的
肺
解剖(医学)
外科
生存分析
比例危险模型
全肺切除术
对数秩检验
淋巴结
内科学
癌症
生物
古生物学
作者
Chunji Chen,Qiming Ni,Yubo Shi,Shijie Fu,Xufeng Pan,Yiyang Wang,Jun Yang,Rui Wang
出处
期刊:Translational cancer research
[AME Publishing Company]
日期:2019-04-01
卷期号:8 (2): 574-582
被引量:2
标识
DOI:10.21037/tcr.2019.03.18
摘要
To determine the clinical prognosis after sublobectomy versus lobectomy in elderly patients ≥75 years old with stage I invasive lung adenocarcinoma ≤3 cm in size.In patients ≥75 years old, 255 patients were diagnosed with stage I invasive lung adenocarcinoma ≤3 cm in size between 2010 and 2014 in Shanghai Chest Hospital, they were all treated with sublobectomy or lobectomy. Potential confounding factors that consisted in the baseline characteristics of these two groups was balanced by the method of propensity score matching (PSM). The stratified analysis was conducted to compare the relapse-free survival (RFS) and lung cancer special survival (LCSS) rates in the sublobectomy and lobectomy groups.As for the 255 patients, 112 cases conducted sublobectomy and 143 with lobectomy. Significant difference existed in RFS before (P=0.002) and after (P=0.010) PSM. Similarly, we still recognized significant difference in LCSS between the two groups before (log-rank P<0.001) or after (log-rank P=0.002) PSM. We still identified different RFS or LCSS rates between the stratified tumor size group and the stratified lymph node dissection group after adjustment of PSM.Lobectomy showed a survival advantage for sublobectomy for patient ≥75 years old with stage I lung adenocarcinoma ≤3 cm in size. Considering that lobectomy could get a better prognosis, it should be preferable for the treatment of patient ≥75 years old with stage I lung adenocarcinoma ≤3 cm in size.
科研通智能强力驱动
Strongly Powered by AbleSci AI